HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $56 | -13.8% | 54,710 | -4.4% | 0.00% | – |
Q2 2023 | $65 | -56.4% | 57,233 | -42.1% | 0.00% | – |
Q1 2023 | $149 | -20.3% | 98,933 | +32.6% | 0.00% | – |
Q4 2022 | $187 | -100.0% | 74,619 | -82.5% | 0.00% | -100.0% |
Q3 2022 | $1,799,000 | +367.3% | 426,354 | +208.4% | 0.00% | – |
Q2 2022 | $385,000 | -51.7% | 138,261 | -0.8% | 0.00% | -100.0% |
Q1 2022 | $797,000 | -69.2% | 139,311 | -50.9% | 0.00% | – |
Q4 2021 | $2,590,000 | +181.2% | 283,728 | +229.6% | 0.00% | – |
Q3 2021 | $921,000 | +38.3% | 86,078 | +100.6% | 0.00% | – |
Q2 2021 | $666,000 | -70.4% | 42,919 | -69.0% | 0.00% | -100.0% |
Q1 2021 | $2,248,000 | +56.5% | 138,626 | +104.3% | 0.00% | 0.0% |
Q4 2020 | $1,436,000 | +35.9% | 67,851 | -4.9% | 0.00% | 0.0% |
Q3 2020 | $1,057,000 | +4.3% | 71,336 | +3.7% | 0.00% | 0.0% |
Q2 2020 | $1,013,000 | +98.2% | 68,794 | +58.3% | 0.00% | – |
Q1 2020 | $511,000 | -75.7% | 43,457 | -51.5% | 0.00% | -100.0% |
Q4 2019 | $2,105,000 | +20.1% | 89,570 | -5.4% | 0.00% | 0.0% |
Q3 2019 | $1,752,000 | +89.6% | 94,654 | +90.3% | 0.00% | 0.0% |
Q2 2019 | $924,000 | -2.2% | 49,732 | +28.6% | 0.00% | 0.0% |
Q1 2019 | $945,000 | +2.7% | 38,679 | +9.0% | 0.00% | 0.0% |
Q4 2018 | $920,000 | -80.6% | 35,493 | -76.3% | 0.00% | -66.7% |
Q3 2018 | $4,749,000 | +331.3% | 150,059 | +429.5% | 0.00% | +200.0% |
Q2 2018 | $1,101,000 | -69.0% | 28,339 | -78.0% | 0.00% | -66.7% |
Q1 2018 | $3,555,000 | +1207.0% | 128,798 | +758.3% | 0.00% | – |
Q4 2017 | $272,000 | -44.4% | 15,006 | -50.5% | 0.00% | – |
Q3 2017 | $489,000 | +455.7% | 30,291 | +375.9% | 0.00% | – |
Q2 2017 | $88,000 | +100.0% | 6,365 | +118.8% | 0.00% | – |
Q1 2017 | $44,000 | -72.8% | 2,909 | -76.4% | 0.00% | – |
Q4 2016 | $162,000 | +1520.0% | 12,338 | +1880.4% | 0.00% | – |
Q3 2016 | $10,000 | -98.2% | 623 | -98.0% | 0.00% | -100.0% |
Q2 2016 | $558,000 | +255.4% | 30,905 | +255.0% | 0.00% | – |
Q1 2016 | $157,000 | +23.6% | 8,706 | +78.1% | 0.00% | – |
Q4 2015 | $127,000 | +1311.1% | 4,888 | +1228.3% | 0.00% | – |
Q3 2015 | $9,000 | -99.8% | 368 | -99.8% | 0.00% | -100.0% |
Q2 2015 | $5,597,000 | +50781.8% | 180,521 | +25542.2% | 0.01% | – |
Q1 2015 | $11,000 | -42.1% | 704 | -62.8% | 0.00% | – |
Q4 2014 | $19,000 | +216.7% | 1,892 | +147.3% | 0.00% | – |
Q3 2014 | $6,000 | -45.5% | 765 | -17.3% | 0.00% | – |
Q2 2014 | $11,000 | – | 925 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG KEVIN C | 760 | $783 | 100.00% |
Velan Capital Investment Management LP | 6,986,744 | $7,196,346 | 5.80% |
Tejara Capital Ltd | 2,109,681 | $2,172,971 | 1.23% |
JW Asset Management, LLC | 2,407,418 | $2,479,641 | 1.07% |
Rubric Capital Management LP | 26,713,503 | $27,514,908 | 1.03% |
GREAT POINT PARTNERS LLC | 4,737,368 | $4,879,489 | 0.89% |
Orchard Capital Management, LLC | 2,142,823 | $2,207,108 | 0.82% |
Clearline Capital LP | 6,149,842 | $6,334,338 | 0.54% |
CM Management, LLC | 450,000 | $463,500 | 0.49% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 327,450 | $337,274 | 0.48% |